Skinvisible, Inc. Deferred Tax Liabilities, Deferred Expense, Capitalized Patent Costs
Skinvisible, Inc. (SKVI) had Deferred Tax Liabilities, Deferred Expense, Capitalized Patent Costs of $20.86 thousand as of 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Notes
us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedPatentCosts · last filed 2022-03-31
- 2021-12-31: Deferred Tax Liabilities, Deferred Expense, Capitalized Patent Costs $20.86K.
- 2020-12-31: Deferred Tax Liabilities, Deferred Expense, Capitalized Patent Costs $16.77K; Deferred Tax Liabilities, Deferred Expense, Capitalized Patent Costs as first filed $16.68K.
- 2020-09-30: Deferred Tax Liabilities, Deferred Expense, Capitalized Patent Costs $16.68K.
- 2020-06-30: Deferred Tax Liabilities, Deferred Expense, Capitalized Patent Costs $14.67K.
| Period end | Deferred Tax Liabilities, Deferred Expense, Capitalized Patent Costs | Deferred Tax Liabilities, Deferred Expense, Capitalized Patent Costs as first filed |
|---|---|---|
| 2021-12-31 | $20.86K 10-K · filed 2022-03-31 | |
| 2020-12-31 | $16.77K 10-K · filed 2022-03-31 | $16.68K 10-K · filed 2021-04-15 |
| 2020-09-30 | $16.68K 10-Q · filed 2020-11-23 | |
| 2020-06-30 | $14.67K 10-Q · filed 2020-08-19 | |
| 2020-03-31 | $870.00 10-Q/A · filed 2020-07-08 | |
| 2019-12-31 | $25.19K 10-K · filed 2020-05-14 | |
| 2019-09-30 | $24.32K 10-Q · filed 2019-12-03 |